Inhibition of interferon-α-induced signaling by hyperosmolarity and hydrophobic bile acids

Biological Chemistry

Volumn 391, Issue 10, 2010, Pages 1175-1187

  Graf, Dirk ^a   Haselow, Katrin ^a   Münks, Ivo ^a   Bode, Johannes G ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

glycochenodeoxycholate; hepatitis C; myxovirus resistance protein A (MxA); osmolyte; STAT

Indexed keywords

ALPHA INTERFERON; GLYCOCHENODEOXYCHOLIC ACID; JANUS KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE TYK2; STAT1 PROTEIN; STAT2 PROTEIN; TAUROCHENODEOXYCHOLIC ACID;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPEROSMOLARITY; HYPEROSMOTIC STRESS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BETAINE; GENE EXPRESSION REGULATION; GLYCOCHENODEOXYCHOLIC ACID; GTP-BINDING PROTEINS; HEP G2 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INTERFERON REGULATORY FACTORS; INTERFERON-ALPHA; OSMOLAR CONCENTRATION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TAUROCHENODEOXYCHOLIC ACID;

HEPATITIS C VIRUS; ORTHOMYXOVIRIDAE;

EID: 78049359382     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2010.108     Document Type: Article

References (53)

1. Abdelmalek, M.F., Angulo, P., Jorgensen, R.A., Sylvestre, P.B., and Lindor, K.D. (2001). Betaine, a promising new agent for patients with non-alcoholic steatohepatitis: results of a pilot study. Am. J. Gastroenterol. 96, 2711-2717.
2. Brigotti, M., Petronini, P.G., Carnicelli, D., Alfieri, R.R., Bonelli, M.A., Borghetti, A.F., and Wheeler, K.P. (2003). Effects of osmolarity, ions and compatible osmolytes on cell-free protein synthesis. Biochem. J. 369, 369-374.
3. Claudinon, J., Gonnord, P., Beslard, E., Marchetti, M., Mitchell, K., Boularan, C., Johannes, L., Eid, P., and Lamaze, C. (2009). Pal-mitoylation of interferon-a (IFN-a) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-a. J. Biol. Chem. 284, 24328-24340.
4. Denizot, F. and Lang, R. (1986). Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89, 271-277.
5. Di Bona, D., Cippitelli, M., Fionda, C., Cammà, C., Licata, A., Santoni, A., and Crax̀i, A. (2006). Oxidative stress inhibits IFN-a-induced antiviral gene expression by blocking the Jak-STAT pathway. J. Hepatol. 45, 271-279.
6. Duong, F.H., Christen, V., Filipowicz, M., and Heim, M.H. (2006). S-Adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro. Hepatology 43, 796-806.
7. Fried, M.W., Shiffman, M.L., Reddy, K.R., Smith, C., Marinos, G., Goncales, F.L., Jr., Häussinger, D., Diago, M., Carosi, G., Dhu-meaux, D., et al. (2002). Peginterferon a-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347, 975-982.
8. Garc̀ia, M.A., Meurs, E.F., and Esteban, M. (2007). The dsRNA protein kinase PKR: virus and cell control. Biochimie 89, 799-811.
9. Graf, D., Kurz, A.K., Reinehr, R., Fischer, R., Kircheis, G., and Häussinger, D. (2002). Prevention of bile acid-induced apoptosis by betaine in rat liver. Hepatology 36, 829-839.
10. Graf, D., Kohlmann, C., Haselow, K., Gehrmann, T., Bode, J.G., and Häussinger, D. (2006). Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and-independent pathways in rat liver. Hepatology 44, 1206-1217.
11. Graf, D., Haselow, K., Münks, I., Bode, J.G., and Häussinger, D. (2008). Caspase-mediated cleavage of the signal-transducing IL-6 receptor subunit gp130. Arch. Biochem. Biophys. 477, 330-338.
12. Haller, O. and Kochs, G. (2002). Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3, 710-717.
13. Holzinger, D., Jorns, C., Stertz, S., Boisson-Dupuis, S., Thimme, R., Weidmann, M., Casanova, J.L., Haller, O., and Kochs, G. (2007). Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 81, 7776-7785.
14. Hong, F., Nguyen, V.A., and Gao, B. (2001). Tumor necrosis factor-a attenuates interferon a signaling in the liver: involvement of SOCS3 and SHP2 and implication in resistance to interferon therapy. FASEB J. 15, 1595-1597.
15. Hovanessian, A.G. and Justesen, J. (2007). The human 2959 oligo-adenylate synthetase family: unique interferon-inducible enzymes catalyzing 2959 instead of 3959 phosphodiester bond formation. Biochimie 89, 779-788.
16. Ji, C., Shinohara, M., Kuhlenkamp, J., Chan, C., and Kaplowitz, N. (2007). Mechanisms of protection by the betaine-homocysteine methyltransferase/betaine system in HepG2 cells and primary mouse hepatocytes. Hepatology 46, 1586-1596.
17. Khare, S., Holgren, C., and Samarel, A.M. (2006). Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase SHP 2. Am. J. Physiol. Gastrointest. Liver Physiol. 291, 1100-1112.
18. Knapp, S., Ladenstein, R., and Galinski, E.A. (1999). Extrinsic protein stabilization by the naturally occurring osmolytes b-hydroxyectoine and betaine. Extremophilis 3, 191-198.
19. Krämer, O.H., Knauer, S.K., Greiner, G., Jandt, E., Reichard, S., Gührs, K.H., Stauber, R.H., Böhmer, F.D., and Heinzel, T. (2009). A phosphorylation-acetylation switch regulates STAT1 signaling. Genes Dev. 23, 223-235.
20. Kühlkamp, T., Keitel, V., Helmer, A., Häussinger, D., and Kubitz, R. (2005). Degradation of the sodium taurocholate cotranspor-ting polypeptide (NTCP) by the ubiquitin-proteasome system. Biol. Chem. 386, 1065-1074.
21. q-taurocholate cotransporting green fluorescent protein in human hepatoblastoma HepG2 cells. Cytotechnology 34, 1-9.
22. MAPK activation and translocation of the bile salt export pump (Bsep) in rats. Gastroenterology 121, 407-419.
23. 2qinter- actions. J. Mol. Biol. 370, 993-1005.
24. Landolfo, S., Gribaudo, G., Angeretti, A., and Gariglio, M. (1995). Mechanisms of viral inhibition by interferons. Pharmacol. Ther. 65, 415-442.
25. Liu, Y. and Bolen, D.W. (1995). The peptide backbone plays a dominant role in protein stabilization by naturally occurring osmo-lytes. Biochemistry 34, 12884-12891.
26. Liu, D., Scafidi, J., Prada, A.E., Zahedi, K., and Davis, A.E. (2002). Nuclear phosphatases and the proteasome in suppression of STAT1 activity in hepatocytes. Biochem. Biophys. Res. Commun. 299, 574-580.
27. Lordnejad, M.R., Schliess, F., Wettstein, M., and Häussinger, D. (2001). Modulation of the heme oxygenase HO-1 expression by hyperosmolarity and betaine in primary rat hepatocytes. Arch. Biochem. Biophys. 388, 285-292.
28. Lornejad-Schäfer, M., Schäfer, C., Richter, L., Grune, T., Häussin-ger, D., and Schliess, F. (2005). Osmotic regulation of MG-132-induced MAP-kinase phosphatase MKP-1 expression in H4IIE rat hepatoma cells. Cell. Physiol. Biochem. 16, 193-206.
29. McHutchison, J.G. and Fried, M.W. (2003). Current therapy for hepatitis C: pegylated interferon and ribavirin. Clin. Liver Dis. 7, 149-161.
30. Miglio, F., Rovati, L.C., Santoro, A., and Setnikar, I. (2000). Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, randomized, parallel-group, placebo-controlled prospective clinical study. Arzneimittelfors-chung 50, 722-727.
31. Neale, G., Lewis, B., Weaver, V., and Panveliwalla, D. (1971). Serum bile acids in liver disease. Gut 12, 145-152.
32. Nielsen, M.B., Christensen, S.T., and Hoffmann, E.K (2008). Effects of osmotic stress on the activity of MAPKs and PDGFR-b-medi-ated signal transduction in NIH-3T3 fibroblasts. Am. J. Physiol. Cell Physiol. 294, 1046-1055.
33. Ortiz-Costa, S., Sorenson, M.M., and Sola-Penna, M. (2008). Beta-ine protects urea-induced denaturation of myosin subfragment-1. FEBS Lett. 275, 3388-3396.
34. Podevin, P., Calmus, Y., Bonnefis, M.T., Veyrunes, C., Chereau, C., and Poupon, R. (1995). Effect of cholestasis and bile acids on interferon-induced 29,59-adenylate synthetase and NK cell activities. Gastroenterology 108, 1192-1198.
35. Podevin, P., Blanc, M.C., Vaubourdolle, M., Veyrunes, C., Bonnefis, M.T., and Poupon, R. (1997). Bile acid inhibition of interferon activity in human lymphocytes: no evidence of oxidative stress. Eur. J. Clin. Invest. 27, 491-496.
36. Podevin, P., Rosmorduc, O., Conti, F., Calmus, Y., Meier, P.J., and Poupon, R. (1999). Bile acids modulate the interferon signaling pathway. Hepatology 29, 1840-1847.
37. Purohit, V., Bode, J.C., Bode, C., Brenner, D.A., Choudhry, M.A., Hamilton, F., Kang, Y.J., Keshavarzian, A., Rao, R., Sartor, R.B., et al. (2007). Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am. J. Clin. Nutr. 86, 14-24.
38. Rakesh, K. and Agrawal, D.K. (2005). Controlling cytokine signaling by constitutive inhibitors. Biochem. Pharmacol. 70, 649-657.
39. Ramiere, C., Scholtes, C., Diaz, O., Icard, V., Perrin-Cocon, L., Trabaud, M.A., Lotteau, V., and Andre, P. (2008). Transactiva-tion of the hepatitis B virus core promoter by the nuclear receptor FXRa. J. Virol. 82, 10832-10840.
40. Reinehr, R., Becker, S., Keitel, V., Eberle, A., Grether-Beck, S., and Häussinger, D. (2005). Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology 129, 2009-2031.
41. Reinehr, R., Becker, S., Braun, J., Eberle, A., Grether-Beck, S., and Häussinger, D. (2006). Endosomal acidification and activation of NADPH oxidase isoforms are upstream events in hyperos-molarity-induced hepatocyte apoptosis. J. Biol. Chem. 281, 23150-23166.
42. Samuel, C.E. (2001). Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778-809.
43. Schäfer, C., Hoffmann, L., Heldt, K., Lordnejad-Schäfer, M.R., Brauers, G., Gehrmann, T., Garrow, T.A., Häussinger, D., Maya-tepek, E., Schwahn, B.C., et al. (2007). Osmotic regulation of betaine homocysteine S-methyltransferase expression in H4IIE rat hepatoma cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292, 1089-1098.
44. Schliess, F. and Häussinger, D. (2002). The cellular hydration state: a critical determinant for cell death and survival. Biol. Chem. 383, 577-583.
45. Schliess, F., Kurz, A.K., vom Dahl, S., and Häussinger, D. (1997). Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. Gastroen-terology 113, 1306-1314.
46. Scholtes, C., Diaz, O., Icard, V., Kaul, A., Bartenschlager, R., Lot-teau, V., and Andre, P. (2008). Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR. J. Hepatol. 48, 192-199.
47. Schwinefus, J.J., Kuprian, M.J., Lamppa, J.W., Merker, W.E., Dorn, K.N., and Muth, G.W. (2007). Human telomerase RNA pseu-doknot and hairpin thermal stability with glycine betaine and urea: preferential interactions with RNA secondary and tertiary structures. Biochemistry 46, 9068-9079.
48. Semrad, K. and Green, R. (2002). Osmolytes stimulate the recons-titution of functional 50S ribosomes from in vitro transcripts of Escherichia coli 23S rRNA. RNA 8, 401-411.
49. Serfaty, L., Giral, P., Loria, A., Andreani, T., Legendre, C., and Poupon, R. (1994). Factors predictive of the response to inter-feron in patients with chronic hepatitis C. J. Hepatol. 21, 12-17.
50. Takaoka, A. and Yanai, H. (2006). Interferon signaling network in innate defence. Cell. Microbiol. 8, 907-922.
51. van Boxel-Dezaire, A.H., Rani, M.R., and Stark, G.R. (2006). Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361-372.
52. Wettstein, M. and Häussinger, D. (1997). Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygeneration injury in the perfused rat liver. Hepatology 26, 1560-1566.
53. Zeuzem, S. (2004). Heterogeneous virologic response rates to inter-feron-based therapy in patients with chronic hepatitis C: who responds less well? Ann. Intern. Med. 140, 370-381.